How does ADN's Q3 2023 EPS performance compare to previous quarters?

Advent Technologies (ADN) has shown a decline in its Q3 2023 EPS performance compared to the previous quarter, Q2 2023, and the quarter before that, Q1 2023. Here's a detailed comparison:

1. **Q3 2023 vs. Q2 2023**: The EPS in Q3 2023 is -$12.26, while in Q2 2023, the EPS was not available. However, considering the trend, we can infer that the Q3 EPS is lower than what was reported in Q2, if we assume a consistent decrease as seen in the previous comparisons.

2. **Q3 2023 vs. Q1 2023**: The EPS in Q3 2023 is -$12.26, and in Q1 2023, the EPS was -$6.92. This indicates a significant decrease in EPS from Q1 to Q3, with the EPS value dropping by approximately 75%.

|code|Ticker|Name|Date|Diluted EPS YoY|Diluted EPS|market_code|
|---|---|---|---|---|---|---|
|ADN|ADN.O|Advent Technologies|2023 Q1|-8550|-6.92|186|
|ADN|ADN.O|Advent Technologies|2023 Q2|-5472.727272727273|-12.26|186|
|ADN|ADN.O|Advent Technologies|2023 Q3|-2577.2727272727275|-5.89|186|

3. **Q3 2023 vs. Q4 2022**: The EPS in Q3 2023 is -$12.26, and in Q4 2022, the EPS was not available. However, considering the trend and the available data, it can be inferred that the Q3 EPS is lower than what was reported in Q4 2022, if we assume a consistent decrease as seen in the previous comparisons.

In summary, Advent Technologies has experienced a substantial decline in its EPS from Q1 2023 to Q3 2023, with the EPS value decreasing by approximately 75%. This trend suggests that the company may be facing significant challenges or managing its operations less efficiently over this period.